83 related articles for article (PubMed ID: 8468129)
1. The Bo-RBC-SCID mouse model for evaluating the efficacy of anti-theilerial drugs.
Hagiwara K; Tsuji M; Ishihara C; Tajima M; Kurosawa T; Iwai H; Takahashi K
Int J Parasitol; 1993 Feb; 23(1):13-6. PubMed ID: 8468129
[TBL] [Abstract][Full Text] [Related]
2. Theileria sergenti infection in the Bo-RBC-SCID mouse model.
Hagiwara K; Tsuji M; Ishihara C; Tajima M; Kurosawa T; Iwai H; Takahashi K
Parasitol Res; 1993; 79(6):466-70. PubMed ID: 8415559
[TBL] [Abstract][Full Text] [Related]
3. Clearance of Theileria sergenti-infected bovine red blood cells in severe combined immune deficiency mice.
Terada Y; Tsuji M; Hagiwara K; Takahashi K; Ishihara C
Vet Parasitol; 1995 Dec; 60(3-4):221-8. PubMed ID: 8747905
[TBL] [Abstract][Full Text] [Related]
4. Serum from Theileria sergenti-infected cattle accelerates the clearance of bovine erythrocytes in SCID mice.
Hagiwara K; Tsuji M; Ishihara C; Tajima M; Kurosawa T; Takahashi K
Parasitol Res; 1995; 81(6):470-4. PubMed ID: 7567904
[TBL] [Abstract][Full Text] [Related]
5. Use of the Bo-RBC-SCID mouse model for isolation of a Babesia parasite from grazing calves in Japan.
Tsuji M; Terada Y; Arai S; Okada H; Ishihara C
Exp Parasitol; 1995 Dec; 81(4):512-8. PubMed ID: 8542992
[TBL] [Abstract][Full Text] [Related]
6. Theileria sergenti proliferates in SCID mice with bovine erythrocyte transfusion.
Tsuji M; Hagiwara K; Takahashi K; Ishihara C; Azuma I; Siddiqui WA
J Parasitol; 1992 Aug; 78(4):750-2. PubMed ID: 1635038
[TBL] [Abstract][Full Text] [Related]
7. A method for rapid and complete substitution of the circulating erythrocytes in SCID mice with bovine erythrocytes and use of the substituted mice for bovine hemoprotozoa infections.
Nakamura Y; Tsuji M; Arai S; Ishihara C
J Immunol Methods; 1995 Dec; 188(2):247-54. PubMed ID: 8551053
[TBL] [Abstract][Full Text] [Related]
8. A method for analysis of cell to cell transmission of Theileria sergenti piroplasms.
Terada Y; Tsuji M; Nakamura Y; Hagiwara K; Takahashi K; Ishihara C
J Vet Med Sci; 1998 Jan; 60(1):115-7. PubMed ID: 9492371
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of [3H]hypoxanthine by short-term cultured Theileria sergenti and its inhibition by drugs.
Kamiyama T; Niinuma S; Ikeda I; Matsubara J
J Parasitol; 1992 Oct; 78(5):856-60. PubMed ID: 1403428
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection.
Haas KM; Taylor KA; MacHugh ND; Kreeger JM; Estes DM
J Leukoc Biol; 2001 Dec; 70(6):931-40. PubMed ID: 11739556
[TBL] [Abstract][Full Text] [Related]
11. Transfusion with xenogeneic erythrocytes into SCID mice and their clearance from the circulation.
Ishihara C; Tsuji M; Hagiwara K; Hioki K; Arikawa J; Azuma I
J Vet Med Sci; 1994 Dec; 56(6):1149-54. PubMed ID: 7696408
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a SCID mouse model having circulating human red blood cells and a possible growth of Plasmodium falciparum in the mouse.
Tsuji M; Ishihara C; Arai S; Hiratai R; Azuma I
Vaccine; 1995; 13(15):1389-92. PubMed ID: 8578814
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the inhibitory effect of N-acetyl-L-cysteine on Babesia and Theileria parasites.
Rizk MA; El-Sayed SAE; AbouLaila M; Yokoyama N; Igarashi I
Exp Parasitol; 2017 Aug; 179():43-48. PubMed ID: 28655583
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of heparin on red blood cell invasion by Theileria sergenti merozoites.
Hagiwara K; Takahashi M; Ichikawa T; Tsuji M; Ikuta K; Ishihara C
Int J Parasitol; 1997 May; 27(5):535-9. PubMed ID: 9193947
[TBL] [Abstract][Full Text] [Related]
15. Mannan decelerates the clearance of human red blood cells in SCID mouse.
Ishihara C; Hiratai R; Tsuji M; Yagi K; Nose M; Azuma I
Immunopharmacology; 1998 Jan; 38(3):223-8. PubMed ID: 9506821
[TBL] [Abstract][Full Text] [Related]
16. A sulfated chitin, SCM-chitin III, inhibits the clearance of human erythrocytes from the blood circulation in erythrocyte-transfused SCID mice.
Ishihara C; Shimakawa S; Tsuji M; Arikawa J; Tokura S
Immunopharmacology; 1995 Feb; 29(1):65-71. PubMed ID: 7768673
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and plasma concentrations of two formulations of buparvaquone in cattle infected with East Coast fever (Theileria parva infection).
Muraguri GR; Ngumi PN; Wesonga D; Ndungu SG; Wanjohi JM; Bang K; Fox A; Dunne J; McHardy N
Res Vet Sci; 2006 Aug; 81(1):119-26. PubMed ID: 16289157
[TBL] [Abstract][Full Text] [Related]
18. Further evaluation of the use of buparvaquone in the infection and treatment method of immunizing cattle against Theileria parva derived from African buffalo (Syncerus caffer).
Ngumi PN; Young AS; Lampard D; Mining SK; Ndungu SG; Lesan AC; Williamson SM; Linyonyi A; Kariuki DP
Vet Parasitol; 1992 Jun; 43(1-2):15-24. PubMed ID: 1496799
[TBL] [Abstract][Full Text] [Related]
19. Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo.
Beshbishy AM; Batiha GE; Yokoyama N; Igarashi I
Parasit Vectors; 2019 May; 12(1):269. PubMed ID: 31138282
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of Theileria annulata and Theileria parva macroschizont-infected bovine cells in scid mice.
Fell AH; Preston PM
Int J Parasitol; 1993 Feb; 23(1):77-87. PubMed ID: 8468139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
